[CPIX] Cumberland Pharmaceuticals Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 75.75 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 5.42 Change: 0.02 (0.28%)
Ext. hours: Change: 0 (0%)

chart CPIX

Refresh chart

Strongest Trends Summary For CPIX

CPIX is in the medium-term up 15% in 2 months. In the long-term down -29% below S&P in 3 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the hospital acute care and gastroenterology markets in the United States. The company?s principal products comprise Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. Its products also include Omeclamox-Pak, a triple therapy combination medication for the treatment of Helicobacter pylori infection and duodenal ulcer disease; and Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome. The company markets and sells its products through sales representatives and managers. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tenne

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding16.22 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -10.9% Sales Growth - Q/Q-6.88% P/E
P/E To EPS Growth P/S2.02 P/BV0.95 Price/Cash Per Share1.43
Price/Free Cash Flow11.6 ROA2.37% ROE2.75% ROI
Current Ratio5.68 Quick Ratio5.29 Long Term Debt/Equity Debt Ratio0.15
Gross Margin86.23% Operating Margin8.41% Net Profit Margin5.82% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-1.68 M Cash From Investing Activities-1.17 M Cash From Operating Activities2.03 M Gross Profit7.52 M
Net Profit50 K Operating Profit Total Assets92.19 M Total Current Assets67.55 M
Total Current Liabilities11.89 M Total Debt Total Liabilities12.82 M Total Revenue8.69 M
Technical Data
High 52 week7 Low 52 week4.73 Last close5.53 Last change-3.49%
RSI53.94 Average true range0.39 Beta0.5 Volume2.51 K
Simple moving average 20 days-0.63% Simple moving average 50 days2.15% Simple moving average 200 days-4.66%
Performance Data
Performance Week-4.49% Performance Month11.72% Performance Quart-1.78% Performance Half-8.6%
Performance Year-0.9% Performance Year-to-date-8.29% Volatility daily3.24% Volatility weekly7.24%
Volatility monthly14.85% Volatility yearly51.42% Relative Volume74.79% Average Volume33.67 K
New High New Low

News

2019-11-05 17:45:10 | Cumberland Pharmaceuticals CPIX Dips More Than Broader Markets: What You Should Know

2019-11-05 11:24:04 | What's in Store for Cumberland Pharma CPIX in Q3 Earnings?

2019-11-05 10:32:03 | Cumberland Pharmaceuticals CPIX to Report Q3 Results: Wall Street Expects Earnings Growth

2019-11-05 09:35:00 | Cumberland Pharmaceuticals To Announce Third Quarter 2019 Financial Results

2019-11-02 10:30:11 | Is Cumberland Pharmaceuticals NASDAQ:CPIX Using Too Much Debt?

2019-10-30 17:45:09 | Cumberland Pharmaceuticals CPIX Outpaces Stock Market Gains: What You Should Know

2019-10-24 17:45:09 | Cumberland Pharmaceuticals CPIX Stock Sinks As Market Gains: What You Should Know

2019-10-16 17:50:09 | Cumberland Pharmaceuticals CPIX Dips More Than Broader Markets: What You Should Know

2019-10-15 09:35:00 | New Study Reveals Superiority Of Vibativ® Over Vancomycin In Select Patients With Bacterial Pneumonia

2019-10-10 17:45:09 | Cumberland Pharmaceuticals CPIX Outpaces Stock Market Gains: What You Should Know

2019-10-04 17:45:09 | Cumberland Pharmaceuticals CPIX Stock Sinks As Market Gains: What You Should Know

2019-09-26 11:01:03 | New Strong Buy Stocks for September 26th

2019-09-25 12:25:50 | Does Cumberland Pharmaceuticals Inc.'s NASDAQ:CPIX CEO Pay Matter?

2019-09-24 09:35:00 | Cumberland Pharmaceuticals Announces FDA Orphan Drug Grant Award For New Phase II Clinical Program

2019-09-19 08:01:12 | New Strong Buy Stocks for September 19th

2019-09-13 09:25:01 | Cumberland Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?

2019-09-12 10:26:02 | New Strong Buy Stocks for September 12th

2019-09-12 09:00:01 | Cumberland CPIX Upgraded to Strong Buy: What Does It Mean for the Stock?

2019-09-10 11:46:03 | Theravance Announces Positive Early Data on JAK Inhibitor

2019-09-09 09:50:01 | New Strong Buy Stocks for September 9th

2019-09-06 10:33:28 | Edited Transcript of CPIX earnings conference call or presentation 14-Aug-19 8:30pm GMT

2019-09-06 08:45:12 | Here is Why Growth Investors Should Buy Cumberland CPIX Now

2019-09-05 09:38:01 | New Strong Buy Stocks for September 5th

2019-08-21 08:45:12 | Here is Why Growth Investors Should Buy Cumberland CPIX Now

2019-08-14 17:25:09 | Cumberland Pharmaceuticals CPIX Q2 Earnings Beat Estimates

2019-08-14 16:05:00 | Cumberland Pharmaceuticals Reports 14% Revenue Growth In The Second Quarter

2019-08-14 07:24:43 | Q2 Earnings Preview For Cumberland

2019-08-07 13:45:00 | Cumberland Pharmaceuticals To Announce Second Quarter 2019 Financial Results

2019-08-06 10:30:02 | Cumberland Pharmaceuticals CPIX Earnings Expected to Grow: What to Know Ahead of Q2 Release

2019-07-18 14:33:10 | New antibiotics desperately needed for rising tide of drug-resistant ‘superbugs’

2019-07-12 14:30:01 | When Will Cumberland Pharmaceuticals Inc. NASDAQ:CPIX Turn A Profit?

2019-07-05 10:09:02 | Dova Pharmaceuticals DOVA in Focus: Stock Moves 9.1% Higher

2019-06-26 08:32:12 | Acer Shares Down on FDA's CRL for Genetic Disorder Treatment

2019-06-25 17:50:09 | Cumberland Pharmaceuticals CPIX Gains As Market Dips: What You Should Know

2019-06-25 09:28:01 | Why Taro Pharmaceutical TARO Could Be Positioned for a Slump

2019-06-19 17:50:09 | Cumberland Pharmaceuticals CPIX Stock Sinks As Market Gains: What You Should Know

2019-06-19 08:25:21 | The city's newest public company wants to build a new industry in Nashville

2019-06-18 10:25:56 | Publicly traded San Diego firm moving HQ to Nashville

2019-06-04 10:08:02 | The Zacks Analyst Blog Highlights: Flexible Solutions International, Qiwi, Cumberland Pharmaceuticals, CECO Environmental and Entravision Communications

2019-06-04 09:30:01 | Has Cumberland Pharmaceuticals CPIX Outpaced Other Medical Stocks This Year?

2019-06-04 08:39:12 | Nektar NKTR in Focus: Stock Moves 8.8% Higher

2019-06-03 08:31:12 | 5 Stocks That Survived May's Market Mayhem

2019-05-23 09:11:01 | New Strong Buy Stocks for May 23rd

2019-05-23 09:00:01 | Cumberland CPIX Upgraded to Strong Buy: Here's What You Should Know

2019-05-17 08:45:12 | Is Cumberland CPIX a Solid Growth Stock? 3 Reasons to Think " Yes "

2019-05-15 09:35:00 | Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement For Distribution In China

2019-05-14 21:04:40 | Edited Transcript of CPIX earnings conference call or presentation 14-May-19 8:30pm GMT

2019-05-14 17:45:09 | Cumberland Pharmaceuticals CPIX Q1 Earnings and Revenues Beat Estimates

2019-05-14 16:41:34 | Cumberland: 1Q Earnings Snapshot

2019-05-14 16:05:00 | Nashville health care company's strategic review leads it to China